+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sinopharm Group Co Ltd (1099) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 55 Pages
  • May 2023
  • GlobalData
  • ID: 1367935
Sinopharm Group Co Ltd (1099) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp, distributes pharmaceutical and healthcare products. The company provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceuticals, medical products and supplies, and other healthcare products. It serves hospitals, primary health service institutions, and retail drug stores. Sinopharm also manufactures and sells pharmaceuticals, chemical reagents, laboratory supplies, and carries out the development of pharmaceutical, medical services, and other health-related industries. The company manages a chain of medicine stores in China through direct operations and franchises to market pharmaceutical and healthcare products. Sinopharm is headquartered in Shanghai, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Sinopharm Group Co Ltd - Key Facts
  • Sinopharm Group Co Ltd - Key Employees
  • Sinopharm Group Co Ltd - Key Employee Biographies
  • Sinopharm Group Co Ltd - Major Products and Services
  • Sinopharm Group Co Ltd - History
  • Sinopharm Group Co Ltd - Company Statement
  • Sinopharm Group Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Sinopharm Group Co Ltd - Business Description
  • Business Segment: Medical Devices
  • Overview
  • Performance
  • Business Segment: Other Business
  • Overview
  • Performance
  • Business Segment: Pharmaceutical Distribution
  • Overview
  • Performance
  • Business Segment: Retail Pharmacy
  • Overview
  • Performance
  • R&D Overview
  • Sinopharm Group Co Ltd - Corporate Strategy
  • Sinopharm Group Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Sinopharm Group Co Ltd - Strengths
  • Sinopharm Group Co Ltd - Weaknesses
  • Sinopharm Group Co Ltd - Opportunities
  • Sinopharm Group Co Ltd - Threats
  • Sinopharm Group Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Sinopharm Group Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 17, 2023: TOP22! Sinopharm ranked in the 2023 Top 100 brand value list of Chinese listed companies
  • May 17, 2023: Innovation leads development and embraces the digital future-Sinopharm appears at the 87th CMEF
  • Mar 24, 2023: Sinopharm Group Announces Financial Data for the Year Ended 31 December 2022
  • Mar 15, 2023: Preliminary financial data of Sinopharm accord for the year 2022
  • Mar 14, 2023: Elekta and Sinopharm collaborate to improve access and quality of cancer care in China
  • Jan 04, 2023: Sinopharm Group Proposed Appointment of Non-Executive Director And Supervisor
  • Oct 25, 2022: Sinopharm Group Announces Principal Financial Data Of Cnmdc For The Nine Months Ended 30 September 2022
  • Oct 21, 2022: Sinopharm Group Announces Principal Financial Data For The Third Quarter Ended 30 September 2022Pdf
  • Aug 19, 2022: Preliminary financial data of Sinopharm Accord for the six months ended 30 June 2022
  • Apr 28, 2022: Sinopharm Group Co. Announces Change of Date of Extraordinary General Meeting
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Sinopharm Group Co Ltd, Key Facts
  • Sinopharm Group Co Ltd, Key Employees
  • Sinopharm Group Co Ltd, Key Employee Biographies
  • Sinopharm Group Co Ltd, Major Products and Services
  • Sinopharm Group Co Ltd, History
  • Sinopharm Group Co Ltd, Subsidiaries
  • Sinopharm Group Co Ltd, Joint Venture
  • Sinopharm Group Co Ltd, Key Competitors
  • Sinopharm Group Co Ltd, Ratios based on current share price
  • Sinopharm Group Co Ltd, Annual Ratios
  • Sinopharm Group Co Ltd, Interim Ratios
  • Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Sinopharm Group Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sinopharm Group Co Ltd, Performance Chart (2018 - 2022)
  • Sinopharm Group Co Ltd, Ratio Charts
  • Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Wai Yuen Tong Medicine Holdings Ltd
  • Tasly Pharmaceutical Group Co Ltd
  • Sinobiopharma Inc
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd